MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2
Open Access
- 19 December 2020
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-13
Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related death around the world whose recurrence and metastasis rate is high. Due to the underlying unclear pathogenesis, it is hard so far to predict the tumorigenesis and prevent its recurrence. YAP/TAZ has been reported to be activated and functioned as a potential oncogene in multiple cancer types and proved to be essential for the carcinogenesis of most solid tumors. In the present study, we found that YAP/TAZ was markedly upregulated in CRC tissues comparing with the adjacent noncancerous tissues due to the downregulation of LATS2, the main upstream regulator. We further identified miR-429 as a direct regulator of LATS2-YAP/TAZ activation, suggesting that the miR-429-LATS2-YAP/TAZ might be novel effective diagnostic axis and therapeutic targets for CRC.Keywords
Funding Information
- Health and Family Planning Commission of Sichuan Province (201840359, 81874201)
- National Natural Science Foundation of China (201840359, 81874201)
This publication has 46 references indexed in Scilit:
- miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinomaMolecular and Cellular Biochemistry, 2014
- miR-429 Identified by Dynamic Transcriptome Analysis Is a New Candidate Biomarker for Colorectal Cancer PrognosisOMICS: A Journal of Integrative Biology, 2014
- The Role of MicroRNA-200 in Progression of Human Colorectal and Breast CancerPLOS ONE, 2013
- MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinomaCellular Oncology, 2013
- Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer CellsPLOS ONE, 2013
- MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2Cancer Letters, 2013
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer CellsCell, 2011
- miR-429 Modulates the expression of c-myc in human gastric carcinoma cellsEuropean Journal of Cancer, 2011
- MicroRNA expression profiles classify human cancersNature, 2005
- The functions of animal microRNAsNature, 2004